Impact of the Major BCR-ABL1 Transcript Type on Clinical and Biological Parameters and Molecular Response in Patients With Chronic Myeloid Leukemia

Aim: In chronic myeloid leukemia (CML), the impact of MBCR-ABL1 major transcript type on disease phenotype and response to treatment still controversial to date. This work aims to study the influence of Mb3a2 and Mb2a2 transcripts on clinico-biological parameters and the molecular response in patien...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mourad Nachi, Ibtissem Kihel, Badra Entasoltane, Mohamed Brahimi, Nabil Yafour, Djaoued Guella, Amine Abed, Mohamed A Bekadja
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2022-04-01
coleção:	Hematology/Oncology and Stem Cell Therapy
Assuntos:	bcr-abl1 transcript chronic myeloid leukemia imatinib therapy major molecular response qrt-pcr
Acesso em linha:	https://journals.lww.com/10.1016/j.hemonc.2020.08.003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!